Beractant
Beractant
Beractant (pronounced as ber-AK-tant) is a drug used in the treatment of RDS in newborns. It is a synthetic form of surfactant, a substance naturally produced in the lungs to help with breathing.
Etymology
The term "Beractant" is derived from the words "bovine" and "surfactant". The drug is a bovine lung extract containing phospholipids, neutral lipids, fatty acids, and surfactant-associated proteins such as SP-B and SP-C.
Usage
Beractant is used to prevent and treat RDS in premature infants at high risk for RDS. The drug is usually given by a healthcare professional in a hospital setting. The dosage is based on the infant's weight, medical condition, and response to therapy.
Related Terms
- Surfactant: A substance that tends to reduce the surface tension of a liquid in which it is dissolved.
- RDS: A breathing disorder that affects newborns, usually those who are premature.
- Phospholipids: A class of lipids that are a major component of all cell membranes.
- Fatty Acids: Carboxylic acids with long aliphatic chains, which are either saturated or unsaturated.
See Also
- Pulmonary Surfactant: A surface-active lipoprotein complex formed by type II alveolar cells.
- Neonatology: A subspecialty of pediatrics that consists of the medical care of newborn infants, especially the ill or premature newborn.
External links
- Medical encyclopedia article on Beractant
- Wikipedia's article - Beractant
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski